Aspoxicillin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Aspoxicillin 是一种针对胸膜肺炎放线杆菌的广谱抗菌剂，MIC90 < 或 = 0.05 μg/ml。

Aspoxicillin is a broad-spectrum antimicrobial agent against Actinobacillus pleuropneumoniae with of MIC90 < or = 0.05 μg/ml.(In Vitro):Aspoxicillin induces postantibiotic effects against Staphylococcus aureus Smith of 1.7 h in vitro .Growth suppression by sub-MICs of aspoxicillin was examined in vitro using either previously unexposed bacterial cells or cells which had been pre-exposed to twice the MIC of aspoxicillin for 2 h .(In Vivo):Aspoxicillin has a long half-life in mouse serum of 55 minutes. Aspoxicillin induces PAEs against Staphylococcus aureus Smith of 5.2 h in vivo in a thigh infection model in neutropenic mice .

Aspoxicillin is a semisynthetic penicillin derivative Aspoxicillin induces postantibiotic effects (PAEs) against Staphylococcus aureus Smith of 1.7 h in vitro.

Aspoxicillin induces PAEs against Staphylococcus aureus Smith of 5.2 h in vivo in a thigh infection model in neutropenic mice.

——

Others

Other Targets

——

——

——

63358-49-6

493.54

C21H27N5O7S

>98% (HPLC)

In Vitro:?H2O : 25 mg/mL (50.66 mM)

[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N([C@@H](C(N)=O)c1ccc(O)cc1)C(=O)[C@@H](CC(N)=O)NC)C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years